Antipsychotic drugs and safety concerns for breast-feeding infants

Tapan Parikh; Dharmendra Goyal; Jonathan R. Scarff; Steven Lippmann

doi:10.14423/SMJ.0000000000000190

Antipsychotic drugs and safety concerns for breast-feeding infants

Tapan Parikh, Dharmendra Goyal, Jonathan R. Scarff, Steven Lippmann^*

^*Corresponding author for this work

Psychiatry and Behavioral Sciences

Research output: Contribution to journal › Review article › peer-review

15 Scopus citations

Abstract

Antipsychotic drugs prescribed to treat psychiatric symptoms during the postpartumperiod are secreted into breastmilk. Because breast-feeding is crucial to infant development, it is important to select a medication that poses the fewest adverse consequences. Aripiprazole, haloperidol, perphenazine, and trifluoperazine demonstrate no known developmental dangers. Olanzapine, quetiapine, and risperidone are cited as safe, although monitoring is recommended. Chlorpromazine and clozapine may induce developmental concerns. There are limited safety data for asenapine, fluphenazine, iloperidone, loxapine, lurasidone, paliperidone, pimozide, thioridazine, thiothixene, and ziprasidone.

Original language	English (US)
Pages (from-to)	686-688
Number of pages	3
Journal	Southern Medical Journal
Volume	107
Issue number	11
DOIs	https://doi.org/10.14423/SMJ.0000000000000190
State	Published - 2014

Keywords

Antipsychotic drugs
Atypical antipsychotic medications
Breast-feeding
Lactation
Typical antipsychotic agents

ASJC Scopus subject areas

General Medicine

Access to Document

10.14423/SMJ.0000000000000190

Cite this

@article{03b3034f54944fd18ce6736a04b2565f,

title = "Antipsychotic drugs and safety concerns for breast-feeding infants",

abstract = "Antipsychotic drugs prescribed to treat psychiatric symptoms during the postpartumperiod are secreted into breastmilk. Because breast-feeding is crucial to infant development, it is important to select a medication that poses the fewest adverse consequences. Aripiprazole, haloperidol, perphenazine, and trifluoperazine demonstrate no known developmental dangers. Olanzapine, quetiapine, and risperidone are cited as safe, although monitoring is recommended. Chlorpromazine and clozapine may induce developmental concerns. There are limited safety data for asenapine, fluphenazine, iloperidone, loxapine, lurasidone, paliperidone, pimozide, thioridazine, thiothixene, and ziprasidone.",

keywords = "Antipsychotic drugs, Atypical antipsychotic medications, Breast-feeding, Lactation, Typical antipsychotic agents",

author = "Tapan Parikh and Dharmendra Goyal and Scarff, {Jonathan R.} and Steven Lippmann",

note = "Publisher Copyright: Copyright {\textcopyright} 2014 by The Southern Medical Association.",

year = "2014",

doi = "10.14423/SMJ.0000000000000190",

language = "English (US)",

volume = "107",

pages = "686--688",

journal = "Southern Medical Journal",

issn = "0038-4348",

publisher = "Lippincott Williams and Wilkins",

number = "11",

}

TY - JOUR

T1 - Antipsychotic drugs and safety concerns for breast-feeding infants

AU - Parikh, Tapan

AU - Goyal, Dharmendra

AU - Scarff, Jonathan R.

AU - Lippmann, Steven

PY - 2014

Y1 - 2014

N2 - Antipsychotic drugs prescribed to treat psychiatric symptoms during the postpartumperiod are secreted into breastmilk. Because breast-feeding is crucial to infant development, it is important to select a medication that poses the fewest adverse consequences. Aripiprazole, haloperidol, perphenazine, and trifluoperazine demonstrate no known developmental dangers. Olanzapine, quetiapine, and risperidone are cited as safe, although monitoring is recommended. Chlorpromazine and clozapine may induce developmental concerns. There are limited safety data for asenapine, fluphenazine, iloperidone, loxapine, lurasidone, paliperidone, pimozide, thioridazine, thiothixene, and ziprasidone.

AB - Antipsychotic drugs prescribed to treat psychiatric symptoms during the postpartumperiod are secreted into breastmilk. Because breast-feeding is crucial to infant development, it is important to select a medication that poses the fewest adverse consequences. Aripiprazole, haloperidol, perphenazine, and trifluoperazine demonstrate no known developmental dangers. Olanzapine, quetiapine, and risperidone are cited as safe, although monitoring is recommended. Chlorpromazine and clozapine may induce developmental concerns. There are limited safety data for asenapine, fluphenazine, iloperidone, loxapine, lurasidone, paliperidone, pimozide, thioridazine, thiothixene, and ziprasidone.

KW - Antipsychotic drugs

KW - Atypical antipsychotic medications

KW - Breast-feeding

KW - Lactation

KW - Typical antipsychotic agents

UR - http://www.scopus.com/inward/record.url?scp=84922393977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922393977&partnerID=8YFLogxK

U2 - 10.14423/SMJ.0000000000000190

DO - 10.14423/SMJ.0000000000000190

M3 - Review article

C2 - 25365434

AN - SCOPUS:84922393977

SN - 0038-4348

VL - 107

SP - 686

EP - 688

JO - Southern Medical Journal

JF - Southern Medical Journal

IS - 11

ER -

Antipsychotic drugs and safety concerns for breast-feeding infants

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this